GRh2 inhibits the migratory ability of HepG2 HCC cells by recruiting HDAC, suppressing AP-1 transcription factors, and reducing MMP3 expression levels (Zhang K et al., 2019). This evidence concerns the gene FOS and hepatocellular carcinoma.